Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal Tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal Tumors

Published:2018-10-01 Issue:2 Volume:25 Page:609-618
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Gebreyohannes Yemarshet K.,Wozniak Agnieszka,Zhai Madalina-Elena,Wellens Jasmien,Cornillie Jasmien,Vanleeuw Ulla,Evans Erica,Gardino Alexandra K.,Lengauer Christoph,Debiec-Rychter Maria,Sciot Raf^ORCID,Schöffski Patrick^ORCID

Funder

Blueprint Medicines

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene Mutations in Gastrointestinal Stromal Tumors: Advances in Treatment and Mechanism Research;Global Medical Genetics;2024-08-22

2. Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?;Cancers;2024-02-23

3. KIT/PDGFRA inhibitors for the treatment of gastrointestinal stromal tumors: getting to the gist of the problem;Expert Opinion on Investigational Drugs;2024-02-14

4. Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007–001 Studies;Clinical Cancer Research;2024-01-05

5. Molecular pathology of gastrointestinal stromal tumors;Diagnostic Molecular Pathology;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP